OrbiMed Capital GP IX LLC
CIK 1920574
Transactions on file
5
Open-market buys
4
Win rate (buys)
100%
4 scored
Avg % since filing (buys)
+435.5%
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-08-11 | 2026-08-07 | BRVE Braveheart Bio, Inc. | Director10% | Buy | 273,333 | $4.92M | +60.6% | open → |
| 2026-08-11 | 2026-08-07 | BRVE Braveheart Bio, Inc. | Director10% | Buy | 1,666,667 | $30.00M | +60.6% | open → |
| 2026-08-11 | 2026-08-07 | BRVE Braveheart Bio, Inc. | Director10% | C | 9,132,420 | $0.00 | — | open → |
| 2025-09-02 | 2025-08-25 | STTK Shattuck Labs, Inc. | Director | Buy | 1,051,021 | $914.4K | +810.3% | open → |
| 2025-09-02 | 2025-08-25 | STTK Shattuck Labs, Inc. | Director | Buy | 5,255,106 | $4.57M | +810.3% | open → |
